Cargando…
Use of Surrogate end points in HTA
The different actors involved in health system decision-making and regulation have to deal with the question which are valid parameters to assess the health value of health technologies. So called surrogate endpoints represent in the best case preliminary steps in the casual chain leading to the rel...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
German Medical Science GMS Publishing House
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3011277/ https://www.ncbi.nlm.nih.gov/pubmed/21289899 http://dx.doi.org/10.3205/hta000074 |